Guj. Themis Bio.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
351.75
-6.45 (-1.8%)
BSENSE

Nov 20

BSE+NSE Vol: 52.19 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Aarti Drugs
Morepen Labs.
Kwality Pharma
IOL Chemicals
Gufic BioScience
SMS Pharma.
Senores Pharma.
Evonile Pharma
Guj. Themis Bio.
Supriya Lifesci.
Zota Health Care
Why is Gujarat Themis Biosyn Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 9.20% and Operating profit at 4.02% over the last 5 years
2
The company has declared Negative results for the last 3 consecutive quarters
  • PAT(Q) At Rs 8.47 cr has Fallen at -30.4% (vs previous 4Q average)
  • ROCE(HY) Lowest at 3.76%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 9.99 times
3
With ROCE of 3.7, it has a Very Expensive valuation with a 3 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -16.81%, its profits have fallen by -11.2%
4
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -2.27% over the previous quarter and collectively hold 16.45% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.37% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -16.81% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Guj. Themis Bio. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Guj. Themis Bio.
-16.81%
-0.31
54.16%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.20%
EBIT Growth (5y)
4.02%
EBIT to Interest (avg)
53.44
Debt to EBITDA (avg)
1.34
Net Debt to Equity (avg)
0.64
Sales to Capital Employed (avg)
0.71
Tax Ratio
25.34%
Dividend Payout Ratio
14.97%
Pledged Shares
0
Institutional Holding
16.45%
ROCE (avg)
33.42%
ROE (avg)
25.33%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
195
Industry P/E
40
Price to Book Value
4.34
EV to EBIT
83.01
EV to EBITDA
66.35
EV to Capital Employed
3.04
EV to Sales
29.38
PEG Ratio
NA
Dividend Yield
0.19%
ROCE (Latest)
3.67%
ROE (Latest)
4.06%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 92.22 cr

NET SALES(Q)

Highest at Rs 47.46 cr

-19What is not working for the Company
PAT(Q)

At Rs 8.47 cr has Fallen at -30.4% (vs previous 4Q average

ROCE(HY)

Lowest at 3.76%

INVENTORY TURNOVER RATIO(HY)

Lowest at 9.99 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.53 times

PBDIT(Q)

Lowest at Rs 17.73 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 37.36%

PBT LESS OI(Q)

Lowest at Rs 7.37 cr.

NON-OPERATING INCOME(Q)

is 33.30 % of Profit Before Tax (PBT

EPS(Q)

Lowest at Rs 0.65

Loading Valuation Snapshot...
Here's what is working for Guj. Themis Bio.
Net Sales - Quarterly
Highest at Rs 47.46 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Highest at Rs 92.22 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Guj. Themis Bio.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 7.37 cr has Fallen at -53.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 15.71 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 8.47 cr has Fallen at -30.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 12.17 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Inventory Turnover Ratio- Half Yearly
Lowest at 9.99 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio- Half Yearly
Lowest at 2.53 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 17.73 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 37.36%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 7.37 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Non Operating Income - Quarterly
is 33.30 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.65
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)